Alnylam Webinar - Patisiran and Revusiran for the Treatment of ATTR Amyloidosis

[georgeturner]

Presentations from the 2016 Alnylam RNAi Roundtable.

Patisiran and Revusiran for the Treatment of Hereditary ATTR Amyloidosis (hATTR).

Overview of ATTR amyloidosis.
Parient perspective.
Q & A session.
Results of Patisiran and Revusiran trials.
Q & A session.

http://edge.media-server.com/m/p/vpak2a5b